San Francisco, CANCT06216756Now EnrollingIRB Ready

Osteochondral Defect Clinical Trial in San Francisco, CA

Access cutting-edge osteochondral defect treatment through this clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.

Sponsored by AlloSource

Quick Self-Assessment

See if you qualify for this San Francisco location

Preparing your pre-screening questions…

Expert Care in San Francisco

Access osteochondral defect specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related osteochondral defect treatment provided free

Apply for This San Francisco Location

Check if you qualify for this osteochondral defect clinical trial in San Francisco, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to San Francisco

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit San Francisco site if eligible
  4. 4Begin participation

About This Osteochondral Defect Study in San Francisco

The primary objective of this study is to obtain evidence of the effectiveness of Cryopreserved Osteochondral Allograft Core in the treatment of osteochondral lesions on the femoral condyle.

Sponsor: AlloSource

Who Can Participate

Inclusion Criteria

Patients are ≥12 years and ≤ 60 years of age at the time of surgery.
Symptomatic patient presenting with moderate to severe pain in the index knee - unresponsive to conservative treatment (i.e., medication, bracing, physical therapy) and/or previous surgical intervention OR unsalvageable lesion that requires transplantation at the discretion of the treating physician.
Radiographically diagnosed, by MRI or CT scans, or through arthroscopy, to have a cartilage defect on the femoral condyle between 0.9-8.0 cm2 in size.
Will be having an osteochondral transplant procedure.
Has a mechanically stable knee or can be mechanically stabilized in the same procedure.
Has a normally aligned knee as confirmed by anatomic comparison to contralateral limb, or \<5° varus or valgus malalignment that has been corrected or will be corrected in same procedure.
Ipsilateral knee compartment has intact menisci or requires partial meniscectomy ≤ 50% resulting in stable menisci.
Confirmation MRI, CT scan, or arthroscopy obtained pre-operatively within 90 days of surgery
Willingness to follow standardized rehabilitation procedures.
Has the ability to understand the requirements of the study, to provide written informed consent, and to comply with the study protocol.

Exclusion Criteria

Bipolar articular cartilage involvement (kissing lesions) of the ipsilateral compartment (i.e., \> than ICRS Grade 2 on the opposing articular surface).
Has had a prior osteochondral allograft transplant procedure in the same knee.
Will be receiving a meniscus allograft transplantation in the same procedure.
Body Mass Index (BMI)of ≥ 35 kg/m2.
Active malignancy: undergoing treatment for tumor or boney traumatic injury or a history of any invasive malignancy (except non-melanoma skin cancer) unless the patient has been treated with curative intent and there have been no clinical signs or symptoms of the malignancy for at least 5 years.
Clinical and/or radiographic disease in the affected joint that includes generalized osteoarthritis, gout or a history of gout or pseudo-gout.
Active local microbial infection or a systemic infection, including HIV, syphilis, Hepatitis B or Hepatitis C.
Currently immunologically suppressed or immunocompromised, or a medical condition requiring radiation and/or chemotherapy.
Unstable cardiovascular, renal, hepatic, endocrine and/or pulmonary disease, cancer, or uncontrolled diabetes.
Has a history of any inflammatory joint arthropathy.
Currently using/chronic on oral corticosteroids.
Received interarticular corticosteroid injection ≤ 90 days prior to surgery.
Received hyaluronic acid injections into the joint space ≤ 45 days prior to surgery.
Is a female patient who is pregnant.
Physically or mentally compromised (i.e., being currently treated for a psychiatric disorder, senile dementia, Alzheimer's disease) in a manner that would compromise his/her ability to participate in the clinical study.
Has a history of substance abuse- (including but not limited to recreational drugs, alcohol) or has been treated in the last 6 months before enrollment for alcohol and/or drug abuse in an in-patient substance abuse program.
Patients who, in the opinion of the Investigator, would not be able or willing to comply with the protocol.
Is currently involved in a study of another investigational product for similar purpose or has been in the previous 90 days.
Has any contraindications for MRI.
Is having the procedure as part of a Worker's Compensation claim.
Is a ward of the state, prisoner, or transient.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in San Francisco?

Yes, this clinical trial (NCT06216756) has an active research site in San Francisco, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Osteochondral Defect Treatment Options in San Francisco, CA

If you're searching for osteochondral defect treatment options in San Francisco, CA, this clinical trial (NCT06216756) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our San Francisco research site is actively enrolling participants for this clinical trial. You'll receive care from experienced osteochondral defect specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all osteochondral defect clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in San Francisco, CA

See all rheumatoid arthritis clinical trials recruiting in San Francisco — not just this study.

Browse Rheumatoid Arthritis Trials in San Francisco →

Browse More Trials by Condition

Rheumatoid Arthritis TrialsAll Conditions →

Ready to Join in San Francisco?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · San Francisco, CA